You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 125 No. 4, April 2007 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  Socioeconomics and Health Services
 •Online Features
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (36)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Medical Practice, Other
 •Ophthalmological Disorders, Other
 •Public Health
 •Public Health, Other
 •Articles for Residents
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Economic Impact of Visual Impairment and Blindness in the United States

Kevin D. Frick, PhD; Emily W. Gower, PhD; John H. Kempen, MD, PhD; Jennifer L. Wolff, PhD

Arch Ophthalmol. 2007;125(4):544-550.

Objectives  To assess the economic impact of excess medical and informal care and the health utility loss associated with visual impairment and blindness in adults aged 40 years and older in the United States.

Methods  Medical Expenditure Panel Survey data from 1996 to 2002 were pooled to estimate the relationship of visual impairment and blindness with total medical expenditures, components of expenditures, days of informal care received, and health utility. Estimates accounting for the complex sampling design were based on regressions including confounders such as comorbidities and demographics. The aggregate economic impact was estimated by projecting average individual effects to the population of individuals with blindness and visual impairment.

Results  Blindness and visual impairment were significantly associated with higher medical care expenditures, a greater number of informal care days, and a decrease in health utility. The home care component of expenditures was most affected by blindness. The aggregate annual economic impact included $5.5 billion spent for medical care and the value of informal care as well as a loss of more than 209 000 quality-adjusted life years.

Conclusions  Visual impairment has a large effect on home care. Any economic analysis of prevention, treatment, and rehabilitation should account for the fraction of the annual monetary cost and loss of quality-adjusted life years that can be averted.


Author Affiliations: Department of Health Policy and Management, Health Services Research and Development Center, Bloomberg School of Public Health (Drs Frick and Wolff) and Department of Ophthalmology, Dana Center for Preventive Ophthalmology (Dr Gower), Johns Hopkins University, Baltimore, Md; and Center for Preventive Ophthalmology and Biostatistics, Department of Ophthalmology, University of Pennsylvania, Philadelphia (Dr Kempen).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Natural History of Age-Related Retinal Lesions That Precede AMD in Mice Fed High or Low Glycemic Index Diets
Weikel et al.
IOVS 2012;53:622-632.
ABSTRACT | FULL TEXT  

Substantial adverse association of visual and vascular comorbidities on visual disability in multiple sclerosis
Marrie et al.
Mult Scler 2011;17:1464-1471.
ABSTRACT | FULL TEXT  

Prevalence of Primary Open Angle Glaucoma in a Rural Adult Chinese Population: The Handan Eye Study
Liang et al.
IOVS 2011;52:8250-8257.
ABSTRACT | FULL TEXT  

A Population-Based Assessment of 24-Hour Intraocular Pressure among Subjects with Primary Open-Angle Glaucoma: The Handan Eye Study
Wang et al.
IOVS 2011;52:7817-7821.
ABSTRACT | FULL TEXT  

Treating patients presenting with advanced glaucoma--should we reconsider current practice?
King et al.
Br J Ophthalmol 2011;95:1185-1192.
ABSTRACT | FULL TEXT  

Economic Cost of Visual Impairment in Japan
Roberts et al.
Arch Ophthalmol 2010;128:766-771.
ABSTRACT | FULL TEXT  

The Cost of Visual Impairment: Purposes, Perspectives, and Guidance
Frick et al.
IOVS 2010;51:1801-1805.
FULL TEXT  

The Cost of Care for People With Impaired Vision in Australia
Keeffe et al.
Arch Ophthalmol 2009;127:1377-1381.
ABSTRACT | FULL TEXT  

High-Rate Internal Pressurization of Human Eyes to Predict Globe Rupture
Bisplinghoff et al.
Arch Ophthalmol 2009;127:520-523.
ABSTRACT | FULL TEXT  

Is Universal Vision Care Coverage the Best Way to Get People to See Their Eye Care Providers?
Kymes and Frick
Arch Ophthalmol 2009;127:335-336.
FULL TEXT  

Prevalence and Causes of Low Vision and Blindness in an Urban Malay Population: The Singapore Malay Eye Study
Wong et al.
Arch Ophthalmol 2008;126:1091-1099.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2007 American Medical Association. All Rights Reserved.